510 related articles for article (PubMed ID: 16690361)
21. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
[TBL] [Abstract][Full Text] [Related]
22. Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
Pathak A; Mårtensson A; Gawariker S; Sharma A; Diwan V; Purohit M; Ursing J
Malar J; 2020 Aug; 19(1):290. PubMed ID: 32795288
[TBL] [Abstract][Full Text] [Related]
23. Molecular Markers for Sulfadoxine/Pyrimethamine and Chloroquine Resistance in Plasmodium falciparum in Thailand.
Kuesap J; Suphakhonchuwong N; Kalawong L; Khumchum N
Korean J Parasitol; 2022 Apr; 60(2):109-116. PubMed ID: 35500892
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
[TBL] [Abstract][Full Text] [Related]
25. High Frequency Mutations in
Yan H; Feng J; Yin JH; Huang F; Kong XL; Lin KM; Zhang T; Feng XY; Zhou SS; Cao JP; Xia ZG
Front Cell Infect Microbiol; 2021; 11():673194. PubMed ID: 34568082
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr/pfdhps alleles.
Nkoli Mandoko P; Rouvier F; Matendo Kakina L; Moke Mbongi D; Latour C; Losimba Likwela J; Ngoyi Mumba D; Bi Shamamba SK; Tamfum Muyembe JJ; Muepu Tshilolo L; Parzy D; Sinou V
J Antimicrob Chemother; 2018 Oct; 73(10):2704-2715. PubMed ID: 30053021
[TBL] [Abstract][Full Text] [Related]
27. Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda.
Zeile I; Gahutu JB; Shyirambere C; Steininger C; Musemakweri A; Sebahungu F; Karema C; Harms G; Eggelte TA; Mockenhaupt FP
Acta Trop; 2012 Jan; 121(1):50-4. PubMed ID: 21996622
[TBL] [Abstract][Full Text] [Related]
28. Molecular monitoring of antimalarial drug resistance among Plasmodium falciparum field isolates from Odisha, India.
Das Sutar SK; Dhangadamajhi G; Kar SK; Ranjit M
Acta Trop; 2013 Apr; 126(1):84-7. PubMed ID: 23357175
[TBL] [Abstract][Full Text] [Related]
29. Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana.
Myers-Hansen JL; Abuaku B; Oyebola MK; Mensah BA; Ahorlu C; Wilson MD; Awandare G; Koram KA; Ngwa AA; Ghansah A
PLoS One; 2020; 15(12):e0233478. PubMed ID: 33284800
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.
Figueiredo P; Benchimol C; Lopes D; Bernardino L; do Rosário VE; Varandas L; Nogueira F
Malar J; 2008 Nov; 7():236. PubMed ID: 19014684
[TBL] [Abstract][Full Text] [Related]
31. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
[TBL] [Abstract][Full Text] [Related]
32. Analysis of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum isolates obtained from asymptomatic pregnant women in Ogun State, Southwest Nigeria.
Fagbemi KA; Adebusuyi SA; Nderu D; Adedokun SA; Pallerla SR; Amoo AOJ; Thomas BN; Velavan TP; Ojurongbe O
Infect Genet Evol; 2020 Nov; 85():104503. PubMed ID: 32805431
[TBL] [Abstract][Full Text] [Related]
33. Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China.
Huang F; Tang L; Yang H; Zhou S; Liu H; Li J; Guo S
Malar J; 2012 Jul; 11():243. PubMed ID: 22839209
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy.
Ogouyèmi-Hounto A; Ndam NT; Kinde Gazard D; d'Almeida S; Koussihoude L; Ollo E; Azagnandji C; Bello M; Chippaux JP; Massougbodji A
Malar J; 2013 May; 12():147. PubMed ID: 23634705
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of sulfadoxine/pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh.
Marma AS; Mita T; Eto H; Tsukahara T; Sarker S; Endo H
Parasitol Int; 2010 Jun; 59(2):178-82. PubMed ID: 20097306
[TBL] [Abstract][Full Text] [Related]
36. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
[TBL] [Abstract][Full Text] [Related]
37. Molecular Epidemiology of Drug Resistance Genes in Plasmodium falciparum Isolates Imported from Nigeria between 2016 and 2020: Continued Emergence of Fully Resistant
Wang X; Zhang X; Chen H; Zhang J; Lu Q; Ruan W; Ling F
Microbiol Spectr; 2022 Oct; 10(5):e0052822. PubMed ID: 36106887
[TBL] [Abstract][Full Text] [Related]
38. Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea.
Koleala T; Karl S; Laman M; Moore BR; Benjamin J; Barnadas C; Robinson LJ; Kattenberg JH; Javati S; Wong RP; Rosanas-Urgell A; Betuela I; Siba PM; Mueller I; Davis TM
Malar J; 2015 Jan; 14():37. PubMed ID: 25626445
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
Schunk M; Kumma WP; Miranda IB; Osman ME; Roewer S; Alano A; Löscher T; Bienzle U; Mockenhaupt FP
Malar J; 2006 Jul; 5():54. PubMed ID: 16817953
[TBL] [Abstract][Full Text] [Related]
40. The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana.
Dosoo DK; Bailey JA; Asante KP; Oppong FB; Niaré K; Opoku-Mensah J; Owusu-Agyei S; Greenwood B; Chandramohan D
PLoS One; 2022; 17(8):e0271489. PubMed ID: 35939419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
